Dr Reddy’s Debuts US Vimovo Rival At Risk
Lupin Has Authorized Generic As Nuvo Cites Patents To 2022
Executive Summary
Dr Reddy’s has announced the launch of the first US generic version of Vimovo delayed-release tablets. However, Nuvo has warned that the at-risk launch infringes patents protecting the arthritis pain treatment until May 2022.